Your browser doesn't support javascript.
loading
Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases.
Wei, Alexander Z; Uriel, Matan; Porcu, Agata; Manos, Michael P; Mercurio, Ann C; Caplan, Michael M; Hulse, Liam; Seedor, Rino S; Holovatska, Marta; Francis, Jasmine; Khan, Shaheer A; McDonnell, Diana E; Bogomolny, Dmitry; Sato, Takami; Marr, Brian P; Haq, Rizwan; Orloff, Marlana; Shoushtari, Alexander; Carvajal, Richard D.
Afiliación
  • Wei AZ; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
  • Uriel M; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
  • Porcu A; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States.
  • Manos MP; Dana-Farber Cancer Institute, Boston, MA, United States.
  • Mercurio AC; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
  • Caplan MM; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
  • Hulse L; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States.
  • Seedor RS; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States.
  • Holovatska M; Dana-Farber Cancer Institute, Boston, MA, United States.
  • Francis J; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Khan SA; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
  • McDonnell DE; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
  • Bogomolny D; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
  • Sato T; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States.
  • Marr BP; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
  • Haq R; Dana-Farber Cancer Institute, Boston, MA, United States.
  • Orloff M; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States.
  • Shoushtari A; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Carvajal RD; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.
Front Oncol ; 12: 961517, 2022.
Article en En | MEDLINE | ID: mdl-36212499
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos